Education - Webinar Upcoming

Closing the evidence gaps in trimester-specific pregnancy reference intervals for biochemical markers of health and disease

  • Date
    Feb 10, 2026
  • Times
    1:00-2:00 pm ET
  • Location
    Live Webinar
  • CE Credits
    1.0 ACCENT
  • Duration
    1 hour
  • Recorded
    Available on demand through 2/10/2027
  • Price
    Free
  • Member Price
    Free

Description

This webinar will outline the challenges of interpreting clinical laboratory testing in pregnancy and discuss the establishment of a trimester-specific reference database for 24 biochemical parameters using a newly derived modern prospective cohort of 135 healthy pregnant women. 

The article will be available in early January for reading in Clinical Chemistry.

Target audience

This activity is designed for physicians, lab supervisors, lab directors (and/or assistant directors), lab managers (supervisory and/or non-supervisory), medical technologists, point-of-care coordinators, pathologists, toxicologists, fellows, residents, in-training individuals, and other laboratory professionals overseeing/conducting within this topic.

Learning objectives

At the end of this session, participants will be able to:

  • Discuss the challenges of interpreting clinical laboratory test results in pregnancy
  • Identify specific biochemical markers where trimester-specific reference intervals are needed based on recent prospective data
  • Outline remaining gaps in evidence-based interpretation across gestation and the post-partum period

Faculty

Moderator

Jason Park, MD, PhD
Editor-in-Chief, Clinical Chemistry
Professor and Chief of Genomic and Molecular Pathology
Department of Pathology  
UT Southwestern Medical Center
Dallas, TX

Speaker

Mary Kathryn Bohn, PhD
Clinical Biochemist
Unity Health
Toronto, Ontario, Canada

Disclosures and statement of independence

The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.

The following faculty reported financial relationships:

  • Jason Park, MD, PhD
    • Ownership interest: OncoSeer Dx

The following faculty reported no financial relationships:

  • Mary Kathryn Bohn, PhD

Content validity

All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR all scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.

Accreditation statement

This activity is submitted for 1.0 ACCENT® continuing education credits.

Successful completion statement

Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email [email protected].